HOME >> MEDICINE >> NEWS
JCI table of contents: May 1, 2007

EDITOR'S PICK

OCT1 required for therapeutic effects of diabetes drug Metformin

The drug metformin is among the most widely prescribed drugs for the treatment of type 2 diabetes and results in an array of therapeutic benefits. Although it has been used for over 30 years, only recently have studies begun to reveal the molecular events responsible for its therapeutic effects. Notably, these studies have shown that metformin acts by phosphorylating the enzyme AMPK, the cellular "energy-sensor", leading to a variety of cellular responses important in diabetic therapy.

A set of mouse and human studies led by Kathleen Giacomini from the University of California, San Francisco and reported in the May 1st issue of the Journal of Clinical Investigation, show that mice lacking organic cation transporter 1 (OCT1) have reduced effects of metformin on AMPK phosphorylation and a decreased ability to control glucose levels. The authors also identified seven mutations in OCT1 in humans that reduce metformin uptake. These studies indicate that OCT1 is important in mediating the therapeutic effects of metformin and that genetic variation in OCT1 in diabetics may contribute to the varied patient responses to this drug.

In an accompanying commentary, Marc Reitman and Eric Schadt from Merck and Rosetta Inpharmatics, respectively, discuss how the identification of individuals that possess specific mutations in certain genes, which are known to affect the action of a particular drug, may eventually help clinicians devise personalized treatment regimes that ensure administration of the right drug for the right person at the right time. They conclude that "tailoring therapeutic choices to the individual should allow lower and better-tolerated doses of drugs that are simultaneously safer and more efficacious. One could eliminate trial-and-error periods of switching among the nine classes of diabetes drugs."

TITLE: Effect of genetic
'"/>

Contact: Brooke Grindlinger
press_releases@the-jci.org
212-342-9006
Journal of Clinical Investigation
1-May-2007


Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. International symposium on fruit, vegetables headed for Houston
2. Stevens Roundtable: Health, Technology & Society, July 11
3. FDA approves ZYFLO CR extended-release tablets for chronic treatment of asthma
4. Once-fatal metabolic disorders treatable, says Stanford/Packard researcher
5. Clinical review -- A psychological approach to the management of irritable bowel syndrome
6. JCI table of contents -- May 17, 2007
7. JCI table of contents: May 10, 2007
8. New treatments needed for irritable bowel syndrome
9. Americans still not eating enough fruits and vegetables, according to 2 recent studies
10. Slow-release morphine reduces level of intractable cough
11. Less television and more gathering around the dinner table prevents

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/15/2019)... ... 2019 , ... Intalere, the healthcare industry leader in delivering ... its Illuminated Path Podcast Series, with the Executive Outlook episode, featuring interviews with ... host Evan Danis, Intalere’s Senior Director of Corporate Communications, shares insight and interviews ...
(Date:5/15/2019)... ... May 15, 2019 , ... SourceLink, an industry-leading omnichannel ... Insurance Strategy. , Stubblefield comes to SourceLink with 10+ years serving in ... corporate marketing and business development. Most recently, he spent several years overseeing ...
(Date:5/14/2019)... ... May 15, 2019 , ... GROW: an awareness journal ... to bloom, facilitating readers to write their way into deeper awareness, cycle through ... creates a mindful space that fosters awareness and transformation. , Christie Havey ...
(Date:5/14/2019)... ... May 14, 2019 , ... The Atlanta Falcons, ... football teams in the U.S. who rely on HydroWorx aquatic therapy pools to ... solutions to accelerate healing,” said Timothy McCarthy, Chief Executive Officer for HydroWorx. ...
(Date:5/14/2019)... ... May 14, 2019 , ... ... in the following majors: Health Science, Exercise Science, Psychology, and Business. These changes ... deans, and Provost, in order to ensure that each program best suits students’ ...
Breaking Medicine News(10 mins):
(Date:5/16/2019)... and FORT WORTH, Texas (PRWEB) , ... May 16, 2019 , ... ... raised $21.7 Million in a Series B financing round. The Series B is ... Partners, participating. , Actuate will use the proceeds of the financing to expand the ...
(Date:5/16/2019)... FRANCISCO (PRWEB) , ... May 16, 2019 , ... ... patient engagement, today announced it has launched Mobile Patient Intake. This new solution ... complete the intake process at their own convenience, on their device of choice, ...
(Date:5/16/2019)... ... May 16, 2019 , ... Though Nefertiti’s Secret—a book by nationally ... via Amazon since April 2019, the author is officially celebrating its publication with a ... invite-only from 5 to 6:30 p.m., then opens to the public at 7 p.m. ...
Breaking Medicine Technology:
Cached News: